Skip to main content
SpringerLink
Log in

Lipid-based Nanoparticles for Nucleic Acid Delivery

  • Expert Review
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Abstract

Lipid-based colloidal particles have been extensively studied as systemic gene delivery carriers. The topic that we would like to emphasize is the formulation/assembly of lipid-based nanoparticles (NP) with diameter under 100 nm for delivering nucleic acid in vivo. NP are different from cationic lipid–nucleic acid complexes (lipoplexes) and are vesicles composed of lipids and encapsulated nucleic acids with a diameter less than 100 nm. The diameter of the NP is an important attribute to enable NP to overcome the various in vivo barriers for systemic gene delivery such as: the blood components, reticuloendothelial system (RES) uptake, tumor access, extracellular matrix components, and intracellular barriers. The major formulation factors that impact the diameter and encapsulation efficiency of DNA-containing NP include the lipid composition, nucleic acid to lipid ratio and formulation method. The particle assembly step is a critical one to make NP suitable for in vivo gene delivery. NP are often prepared using a dialysis method either from an aqueous-detergent or aqueous-organic solvent mixture. The resulting particles have diameters about 100 nm and nucleic acid encapsulation ratios are >80%. Additional components can then be added to the particle after it is formed. This ordered assembly strategy enables one to optimize the particle physico-chemical attributes to devise a biocompatible particle with increased gene transfer efficacy in vivo. The components included in the sequentially assembled NP include: poly(ethylene glycol) (PEG)-shielding to improve the particle pharmacokinetic behavior, a targeting ligand to facilitate the particle–cell recognition and in some case a bioresponsive lipid or pH-triggered polymer to enhance nucleic acid release and intracellular trafficking. A number of groups have observed that a PEG-shielded NP is a robust and modestly effective system for systemic gene or small interfering RNA (siRNA) delivery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. L. C. Heller, K. Ugen, and R. Heller. Electroporation for targeted gene transfer. Expert Opin. Drug Deliv. 2:255–268 (2005).

    Article  PubMed  CAS  Google Scholar 

  2. J. E. Knapp and D. Liu. Hydrodynamic delivery of DNA. Methods Mol. Biol. 245:245–250 (2004).

    PubMed  CAS  Google Scholar 

  3. R. I. Mahato and S. W. Kim. Pharmaceutical Perspectives of Nucleic Acid-based Therapeutics. Taylor & Francis, London, 2002.

    Google Scholar 

  4. P. L. Felgner, T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U. S. A. 84:7413–7417 (1987).

    Article  PubMed  CAS  Google Scholar 

  5. Y. Xu, S. W. Hui, P. Frederik, and F. C. Szoka Jr. Physicochemical characterization and purification of cationic lipoplexes. Biophys. J. 77:341–353 (1999).

    PubMed  CAS  Google Scholar 

  6. J. O. Radler, I. Koltover, T. Salditt, and C. R. Safinya. Structure of DNA–cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 275:810–814 (1997).

    Article  PubMed  CAS  Google Scholar 

  7. N. S. Templeton, D. D. Lasic, P. M. Frederik, H. H. Strey, D. D. Roberts, and G. N. Pavlakis. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat. Biotechnol. 15:647–652 (1997).

    Article  PubMed  CAS  Google Scholar 

  8. L. Huang, M. C. Hung, and E. Wagner. Nonviral Vectors for Gene Therapy. Academic, San Diego, 1999.

    Google Scholar 

  9. M. L. Edelstein, M. R. Abedi, J. Wixon, and R. M. Edelstein. Gene therapy clinical trials worldwide 1989–2004—an overview. J. Gene Med. 6:597–602 (2004).

    Article  PubMed  Google Scholar 

  10. A. D. Judge, V. Sood, J. R. Shaw, D. Fang, K. McClintock, and I. MacLachlan. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23:457–462 (2005).

    Article  PubMed  CAS  Google Scholar 

  11. J. S. Zhang, F. Liu, and L. Huang. Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. Adv. Drug Deliv. Rev. 57:689–698 (2005).

    Article  PubMed  CAS  Google Scholar 

  12. T. L. Jason, J. Koropatnick, and R. W. Berg. Toxicology of antisense therapeutics. Toxicol. Appl. Pharmacol. 201:66–83 (2004).

    Article  PubMed  CAS  Google Scholar 

  13. K. L. Brigham, B. Meyrick, B. Christman, M. Magnuson, G. King, and L. C. Berry, Jr. In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am. J. Med. Sci. 298:278–281 (1989).

    Article  PubMed  CAS  Google Scholar 

  14. L. G. Barron, L. Gagne, and F. C. Szoka, Jr. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. Hum. Gene Ther. 10:1683–1694 (1999).

    Article  PubMed  CAS  Google Scholar 

  15. L. G. Barron and F. C. Szoka. The perplexing delivery mechanism of lipoplexes. In L. Huang, M. C. Hung, and E. Wagner (eds.), Nonviral Vectors for Gene Therapy, Academic, San Diego, 1999, pp. 229–266.

    Chapter  Google Scholar 

  16. C. Tros de Ilarduya, M. A. Arangoa, and N. Duzgunes. Transferrin–lipoplexes with protamine-condensed DNA for serum-resistant gene delivery. Methods Enzymol. 373:342–356 (2003).

    Article  PubMed  CAS  Google Scholar 

  17. S. Simoes, A. Filipe, H. Faneca, M. Mano, N. Penacho, N. Duzgunes, and M. P. de Lima. Cationic liposomes for gene delivery. Expert Opin. Drug Deliv. 2:237–254 (2005).

    Article  PubMed  CAS  Google Scholar 

  18. P. Harvie, F. M. P. Wong, and M. B. Bally. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid–DNA particles. J. Pharm. Sci. 89:652–663 (2000).

    Article  PubMed  CAS  Google Scholar 

  19. W. J. Li, Z. H. Huang, J. A. MacKay, S. Grube, and F. C. Szoka. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanlipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery. J. Gene Med. 7:67–79 (2005).

    Article  PubMed  CAS  Google Scholar 

  20. J. S. Choi, J. A. MacKay, and F. C. Szoka, Jr. Low-pH-sensitive PEG-stabilized plasmid–lipid nanoparticles: preparation and characterization. Bioconjug. Chem. 14:420–429 (2003).

    Article  PubMed  CAS  Google Scholar 

  21. J. J. Wheeler, L. Palmer, M. Ossanlou, I. MacLachlan, R. W. Graham, Y. P. Zhang, M. J. Hope, P. Scherrer, and P. R. Cullis. Stabilized plasmid–lipid particles: construction and characterization. Gene Ther. 6:271–281 (1999).

    Article  PubMed  CAS  Google Scholar 

  22. Y. P. Zhang, L. Sekirov, E. G. Saravolac, J. J. Wheeler, P. Tardi, K. Clow, E. Leng, R. Sun, P. R. Cullis, and P. Scherrer. Stabilized plasmid–lipid particles for regional gene therapy: formulation and transfection properties. Gene Ther. 6:1438–1447 (1999).

    Article  PubMed  CAS  Google Scholar 

  23. L. B. Jeffs, L. R. Palmer, E. G. Ambegia, C. Giesbrecht, S. Ewanick, and I. MacLachlan. A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA. Pharma Res. 22:362–372 (2005).

    Article  CAS  Google Scholar 

  24. M. C. Woodle, L. R. Collins, E. Sponsler, N. Kossovsky, D. Papahadjopoulos, and F. J. Martin. Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential. Biophys. J. 61:902–910 (1992).

    PubMed  CAS  Google Scholar 

  25. P. Opanasopit, M. Nishikawa, and M. Hashida. Factors affecting drug and gene delivery: effects of interaction with blood components. Crit. Rev. Ther. Drug Carr. Syst. 19:191–233 (2002).

    Article  CAS  Google Scholar 

  26. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter. Molecular Biology of the Cell. Garland, New York, 2002.

    Google Scholar 

  27. I. A. Khalil, K. Kogure, H. Akita, and H. Harashima. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev. 58:32–45 (2006).

    Article  PubMed  CAS  Google Scholar 

  28. E. Mastrobattista, M. A. van der Aa, W. E. Hennink, and D. J. Crommelin. Artificial viruses: a nanotechnological approach to gene delivery. Nat. Rev. Drug Discovery 5:115–121 (2006).

    Article  Google Scholar 

  29. S. C. Semple, S. K. Klimuk, T. O. Harasym, N. Dos Santos, S. M. Ansell, K. F. Wong, N. Maurer, H. Stark, P. R. Cullis, M. J. Hope, and P. Scherrer. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim. Biophys. Acta 1510:152–166 (2001).

    Article  PubMed  CAS  Google Scholar 

  30. Z. Huang, W. Li, J. A. MacKay, and F. C. Szoka, Jr. Thiocholesterol-based lipids for ordered assembly of bioresponsive gene carriers. Molec. Ther. 11:409–417 (2005).

    Article  CAS  Google Scholar 

  31. D. P. Siegel and R. M. Epand. The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: implications for membrane fusion mechanisms. Biophys. J. 73:3089–3111 (1997).

    PubMed  CAS  Google Scholar 

  32. M. E. Hayes, D. C. Drummond, D. B. Kirpotin, W. W. Zheng, C. O. Noble, J. W. Park, J. D. Marks, C. C. Benz, and K. Hong. Genospheres: self-assembling nucleic acid–lipid nanoparticles suitable for targeted gene delivery. Gene Ther. 13:646–651 (2006).

    Article  PubMed  CAS  Google Scholar 

  33. R. J. Lee and L. Huang. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271:8481–8487 (1996).

    Article  PubMed  CAS  Google Scholar 

  34. E. Mastrobattista, R. H. Kapel, M. H. Eggenhuisen, P. J. Roholl, D. J. Crommelin, W. E. Hennink, and G. Storm. Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells. Cancer Gene Ther. 8:405–413 (2001).

    Article  PubMed  CAS  Google Scholar 

  35. D. B. Fenske, I. MacLachlan, and P. R. Cullis. Stabilized plasmid–lipid particles: a systemic gene therapy vector. Method Enzymol. 346:36–71 (2002).

    Article  CAS  Google Scholar 

  36. E. Ruoslahti and D. Rajotte. An address system in the vasculature of normal tissues and tumors. Annu. Rev. Immunol. 18:813–827 (2000).

    Article  PubMed  CAS  Google Scholar 

  37. E. S. Scott, J. W. Wiseman, M. J. Evans, and W. H. Colledge. Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex. J. Gene Med. 3:125–134 (2001).

    Article  PubMed  CAS  Google Scholar 

  38. P. Harvie, B. Dutzar, T. Galbraith, S. Cudmore, D. O’Mahony, P. Anklesaria, and R. Paul. Targeting of lipid–protamine–DNA (LPD) lipopolyplexes using RGD motifs. J. Liposome Res. 13:231–247 (2003).

    Article  PubMed  CAS  Google Scholar 

  39. Y. Lu and P. S. Low. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 54:675–693 (2002).

    Article  PubMed  CAS  Google Scholar 

  40. W. Guo, T. Lee, J. Sudimack, and R. J. Lee. Receptor-specific delivery of liposomes via folate-PEG-chol. J. Liposome Res. 10:179–195 (2000).

    Article  CAS  Google Scholar 

  41. L. Xu, K. F. Pirollo, and E. H. Chang. Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy. J. Control. Release 74:115–128 (2001).

    Article  PubMed  CAS  Google Scholar 

  42. W. Yu, K. F. Pirollo, A. Rait, B. Yu, L. M. Xiang, W. Q. Huang, Q. Zhou, G. Ertem, and E. H. Chang. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. Gene Ther. 11:1434–1440 (2004).

    Article  PubMed  CAS  Google Scholar 

  43. S. Han, R. I. Mahato, and S. W. Kim. Water-soluble lipopolymer for gene delivery. Bioconjug. Chem. 12:337–345 (2001).

    Article  CAS  Google Scholar 

  44. R. I. Mahato, M. Lee, S. Han, A. Maheshwari, and S. W. Kim. Intratumoral delivery of p2CMVmIL-12 using water-soluble lipopolymers. Molec. Ther. 4:130–138 (2001).

    Article  CAS  Google Scholar 

  45. X. Gao and L. Huang. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry 35:1027–1036 (1996).

    Article  PubMed  CAS  Google Scholar 

  46. J. Dileo, R. Banerjee, M. Whitmore, J. V. Nayak, L. D. Falo, Jr., and L. Huang. Lipid–protamine–DNA-mediated antigen delivery to antigen-presenting cells results in enhanced anti-tumor immune responses. Molec. Ther. 7:640–648 (2003).

    Article  CAS  Google Scholar 

  47. R. E. Eliaz and F. C. Szoka, Jr. Robust and prolonged gene expression from injectable polymeric implants. Gene Ther. 9:1230–1237, (2002).

    Article  PubMed  CAS  Google Scholar 

  48. N. Shi, Y. Zhang, C. Zhu, R. J. Boado, and W. M. Pardridge. Brain-specific expression of an exogenous gene after i.v. administration. Proc. Natl. Acad. Sci. U. S. A. 98:12754–12759 (2001).

    Article  PubMed  CAS  Google Scholar 

  49. Y. Zhang, C. Zhu, and W. M. Pardridge. Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Molec. Ther. 6:67–72 (2002).

    Article  CAS  Google Scholar 

  50. Y. Zhang, R. J. Boado, and W. M. Pardridge. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. J. Gene Med. 5:1039–1045 (2003).

    Article  PubMed  CAS  Google Scholar 

  51. H. E. Hofland, L. Shephard, and S. M. Sullivan. Formation of stable cationic lipid/DNA complexes for gene transfer. Proc. Natl. Acad. Sci. U. S. A. 93:7305–7309 (1996).

    Article  PubMed  CAS  Google Scholar 

  52. C. Y. Wang and L. Huang. pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc. Natl. Acad. Sci. U. S. A. 84:7851–7855 (1987).

    Article  PubMed  CAS  Google Scholar 

  53. K. W. Mok, A. M. Lam, and P. R. Cullis. Stabilized plasmid–lipid particles: factors influencing plasmid entrapment and transfection properties. Biochim. Biophys. Acta 1419:137–150 (1999).

    Article  PubMed  CAS  Google Scholar 

  54. P. Tam, M. Monck, D. Lee, O. Ludkovski, E. C. Leng, K. Clow, H. Stark, P. Scherrer, R. W. Graham, and P. R. Cullis. Stabilized plasmid–lipid particles for systemic gene therapy. Gene Ther. 7:1867–1874 (2000).

    Article  PubMed  CAS  Google Scholar 

  55. E. Ambegia, S. Ansell, P. Cullis, J. Heyes, L. Palmer, and I. MacLachlan. Stabilized plasmid–lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Biochim. Biophys. Acta 1669:155–163 (2005).

    Article  PubMed  CAS  Google Scholar 

  56. A. Judge, K. McClintock, J. R. Phelps, and I. Maclachlan. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. Molec. Ther. 13:328–337 (2006).

    Article  CAS  Google Scholar 

  57. X. Guo and F. C. Szoka. Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG–diortho ester-lipid conjugate. Bioconjug. Chem. 12:291–300 (2001).

    Article  PubMed  CAS  Google Scholar 

  58. O. T. Jones, J. P. Earnest, and M. G. McNamee. Solubilization and reconstitution of membrane proteins. In J. B. C. Findlay and W. H. Evans (eds.), Biological Membranes: A Practical Approach, IRL, Oxford, 1987, pp. 139–177.

    Google Scholar 

  59. S. Batzri and E. D. Korn. Single bilayer liposomes prepared without sonication. Biochim. Biophys. Acta 298:1015–1019 (1973).

    Article  PubMed  CAS  Google Scholar 

  60. M. J. Campbell. Lipofection reagents prepared by a simple ethanol injection technique. Biotechniques 18:1027–1032 (1995).

    PubMed  CAS  Google Scholar 

  61. P. G. Arscott, C. Ma, J. R. Wenner, and V. A. Bloomfield. DNA condensation by cobalt hexaammine (III) in alcohol–water mixtures: dielectric constant and other solvent effects. Biopolymers 36:345–364 (1995).

    Article  PubMed  CAS  Google Scholar 

  62. J. Piskur and A. Rupprecht. Aggregated DNA in ethanol solution. FEBS Lett. 375:174–178 (1995).

    Article  PubMed  CAS  Google Scholar 

  63. A. L. Bailey and S. M. Sullivan. Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. Biochim. Biophys. Acta 1468:239–252 (2000).

    Article  PubMed  CAS  Google Scholar 

  64. N. Maurer, K. F. Wong, H. Stark, L. Louie, D. McIntosh, T. Wong, P. Scherrer, S. C. Semple, and P. R. Cullis. Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. Biophys. J. 80:2310–2326 (2001).

    PubMed  CAS  Google Scholar 

  65. D. V. Morrissey, J. A. Lockridge, L. Shaw, K. Blanchard, K. Jensen, W. Breen, K. Hartsough, L. Machemer, S. Radka, V. Jadhav, N. Vaish, S. Zinnen, C. Vargeese, K. Bowman, C. S. Shaffer, L. B. Jeffs, A. Judge, I. MacLachlan, and B. Polisky. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23:1002–1007 (2005).

    Article  PubMed  CAS  Google Scholar 

  66. A. D. Judge, G. Bola, A. C. Lee, and I. MacLachlan. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Molec. Ther. 13:494–505 (2006).

    Article  CAS  Google Scholar 

  67. T. S. Zimmermann, A. C. Lee, A. Akinc, B. Bramlage, D. Bumcrot, M. N. Fedoruk, J. Harborth, J. A. Heyes, L. B. Jeffs, M. John, A. D. Judge, K. Lam, K. McClintock, L. V. Nechev, L. R. Palmer, T. Racie, I. Rohl, S. Seiffert, S. Shanmugam, V. Sood, J. Soutschek, I. Toudjarska, A. J. Wheat, E. Yaworski, W. Zedalis, V. Koteliansky, M. Manoharan, H. P. Vornlocher, and I. MacLachlan. RNAi-mediated gene silencing in non-human primates. Nature 441:111–114 (2006).

    Article  PubMed  CAS  Google Scholar 

  68. W. Li and F. C. Szoka. Bioresponsive targeted charge neutral lipid vesicles for systemic gene delivery. In T. Friedmann and J. Rossi (eds.), Gene Transfer: Delivery and Expression of DNA and RNA, Cold Spring Harbor Laboratory Press, New York, 2006, pp. 441–450.

  69. E. A. Murphy, A. J. Waring, S. M. Haynes, and K. J. Longmuir. Compaction of DNA in an anionic micelle environment followed by assembly into phosphatidylcholine liposomes. Nucleic Acids Res. 28:2986–2992 (2000).

    Article  PubMed  CAS  Google Scholar 

  70. E. A. Murphy, A. J. Waring, J. C. Murphy, R. C. Willson, and K. J. Longmuir. Development of an effective gene delivery system: a study of complexes composed of a peptide-based amphiphilic DNA compaction agent and phospholipid. Nucleic Acids Res. 29:3694–3704 (2001).

    Article  PubMed  CAS  Google Scholar 

  71. C. Chittimalla, L. Zammut-Italiano, G. Zuber, and J. P. Behr. Monomolecular DNA nanoparticles for intravenous delivery of genes. J. Am. Chem. Soc. 127:11436–11441 (2005).

    Article  PubMed  CAS  Google Scholar 

  72. G. Zuber, L. Zammut-Italiano, E. Dauty, and J. P. Behr. Targeted gene delivery to cancer cells: Directed assembly of nanometric DNA particles coated with folic acid. Angew. Chem., Int. Ed. Engl. 42:2666–2669 (2003).

    Article  CAS  Google Scholar 

  73. M. Ouyang, J. S. Remy, and F. C. Szoka. Controlled template-assisted assembly of plasmid DNA into nanometric particles with high DNA concentration. Bioconjug. Chem. 11:104–112 (2000).

    Article  PubMed  CAS  Google Scholar 

  74. E. Dauty, J. S. Remy, T. Blessing, and J. P. Behr. Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. J. Am. Chem. Soc. 123:9227–9234 (2001).

    Article  PubMed  CAS  Google Scholar 

  75. T. Blessing, E. Dauty, J. S. Remy, and J. P. Behr. Dimerizable detergents as gene transfer vectors. J. Liposome Res. 10:321–327 (2000).

    Article  CAS  Google Scholar 

  76. J. P. Rolland, B. W. Maynor, L. E. Euliss, A. E. Exner, G. M. Denison, and J. M. DeSimone. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc. 127:10096–10100 (2005).

    Article  PubMed  CAS  Google Scholar 

  77. F. C. Szoka, Y. Xu, and O. Zelphati. How are nucleic acids released in cells from cationic lipid–nucleic acid complexes. J. Liposome Res. 6:567–587 (1996).

    Article  CAS  Google Scholar 

  78. Y. Xu and F. C. Szoka, Jr. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35:5616–5623 (1996).

    Article  PubMed  CAS  Google Scholar 

  79. O. Zelphati and F.C. Szoka Jr. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA 93:11493–11498 (1996).

    Article  PubMed  CAS  Google Scholar 

  80. E. Dauty and A. S. Verkman. Actin cytoskeleton as the principal determinant of size-dependent DNA mobility in cytoplasm: a new barrier for non-viral gene delivery. J. Biol. Chem. 280:7823–7828 (2005).

    Article  PubMed  CAS  Google Scholar 

  81. M. A. Monck, A. Mori, D. Lee, P. Tam, J. J. Wheeler, P. R. Cullis, and P. Scherrer. Stabilized plasmid–lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection. J. Drug Target. 7:439–452 (2000).

    Article  PubMed  CAS  Google Scholar 

  82. D. B. Fenske, I. MacLachlan, and P. R. Cullis. Long-circulating vectors for the systemic delivery of genes. Curr. Opin. Mol. Ther. 3:153–158 (2001).

    PubMed  CAS  Google Scholar 

  83. M. E. Hayes, D. C. Drummond, K. Hong, J. W. Park, J. D. Marks, and D. B. Kirpotin. Assembly of nucleic acid–lipid nanoparticles from aqueous–organic monophases. Biochim. Biophys. Acta 1758:429–442 (2006).

    Article  PubMed  CAS  Google Scholar 

  84. X. Guo, J. A. MacKay, and F. C. Szoka. Mechanism of pH-triggered collapse of phosphatidylethanolamine liposomes stabilized by an ortho ester polyethyleneglycol lipid. Biophys. J. 84:1784–1795 (2003).

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by NIH EB003008 and GM61851. We sincerely thank all former and present members from Szoka group who have contributed to the NLP project.

Author information

Authors and Affiliations

  1. Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry, School of Pharmacy, University of California at San Francisco, San Francisco, CA, 94143-0446, USA

    Weijun Li & Francis C. Szoka Jr.

  2. Bayer Pharmaceuticals Corporation, Berkeley, CA, 94701-1986, USA

    Weijun Li

Authors
  1. Weijun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francis C. Szoka Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francis C. Szoka Jr..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, W., Szoka, F.C. Lipid-based Nanoparticles for Nucleic Acid Delivery. Pharm Res 24, 438–449 (2007). https://doi.org/10.1007/s11095-006-9180-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-006-9180-5

Key words

Search

Navigation